MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling. [electronic resource]
Producer: 20211006Description: 188-200 p. digitalISSN:- 1755-3245
- Animals
- Cardiotoxicity
- Cell Line
- Disease Models, Animal
- Doxorubicin
- Doxycycline -- pharmacology
- Extracellular Matrix -- drug effects
- Fibrosis
- Heart Diseases -- chemically induced
- Human Embryonic Stem Cells -- drug effects
- Humans
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase Inhibitors -- pharmacology
- Mice, Inbred C57BL
- Mitochondria, Heart -- drug effects
- Myocytes, Cardiac -- drug effects
- Phenyl Ethers -- pharmacology
- Protein Kinases -- metabolism
- Proteolysis
- Ventricular Function, Left -- drug effects
- Ventricular Remodeling -- drug effects
- Mice
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.